| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Officer
1 company
Kulkarni Samarth is a Chief Executive Officer at CRSP. Recent filings cover 0 purchases and 109 sales. Those positions are worth an estimated $15.5M at current prices.
Our model assigns Kulkarni Samarth a middling insider score of 68/100, based on 37 past trades. Over a 12-month horizon, 58.1% of those trades were profitable, with an average 12-month return of +7.5%.
Kulkarni Samarth's largest disclosed position is in CRSP as Chief Executive Officer, worth about $15.5M. The recent filings there lean toward selling, a net 1,049,894 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 47,837 | $49.78 | $2,381,325.86 | -13.3% | - | - | |
| Oct 14, 2026 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 4,098 | $49.26 | $201,867.48 | -1.6% | - | - | |
| Mar 23, 2026 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 10,020 | $46.78 | $468,735.60 | -3.8% | +15.4% | - | |
| Mar 16, 2026 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 10,349 | $48.26 | $499,442.74 | -4.0% | +2.9% | - | |
| Mar 11, 2026 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 9,798 | $52.80 | $517,334.40 | -4.0% | +3.1% | - | |
| Feb 19, 2026 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 6,967 | $52.58 | $366,324.86 | -3.0% | - | - | |
| Jan 22, 2026 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sell | 90,000 | $57.40 | $5,166,297.83 | -40.1% | - | - | |
| Oct 17, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 50,895 | $67.91 | $3,456,279.45 | -16.7% | -21.6% | - | |
| Oct 14, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 4,242 | $66.60 | $282,517.20 | -2.0% | -20.3% | - | |
| Aug 18, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 13,081 | $58.15 | $760,660.15 | -5.9% | -3.9% | - |